Clinical Trial Update: A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets [Phase 2]

View source ↗

Summary

A Phase 2b clinical trial evaluating JDB0131 benzenesulfonate tablets for tuberculosis, including multidrug-resistant and rifampicin-resistant forms, is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Rifampicin-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• JDB0131 Benzenesulfonate Tablets (JDB0131 benzenesulfonate)

Snippet

Sponsor: WestVac Biopharma Co., Ltd. | Conditions: Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis | Phase 2 | Status: RECRUITING